Article
From engineered heart tissue to cardiac organoid
1 Jan 2022
Abstract excerpt
The advent of human pluripotent stem cells (hPSCs) presented a new paradigm to employ hPSC-derived cardiomyocytes (hPSC-CMs) in drug screening and disease modeling. However, hPSC-CMs differentiated in conventional two-dimensional systems are structurally and functionally immature. Moreover, these differentiation systems generate predominantly one type of cell. Since the heart includes not only CMs but other cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
